KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Total assets, 2025
- $1.7B
- YoY, 2025
- +78.2%
- 5-year CAGR
- +29.0%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $1.7B | +78.2% |
| 2024 | $978M | +69.9% |
| 2023 | $576M | −4.5% |
| 2022 | $603M | −0.5% |
| 2021 | $606M | +24.4% |
| 2020 | $487M | +317.5% |
| 2019 | $117M | — |